Last night we held a webinar  featuring a panel of experts discussing highlights in myeloma, lymphoma and leukaemia from ASH 2020, and their implications for clinical practice in Australia. If you didn’t get the chance to join us, you can now watch or listen to it here:

Hosted by:

Professor Judith Trotman

Head of Department, Haematology, Concord Hospital, Sydney and Clinical Professor of Medicine, Concord Clinical School, The University of Sydney.

With special guests:

Professor Andrew Spencer

Head of the Malignant Haematology and Stem Cell Transplantation Service at The Alfred Hospital, Professor of Haematology at Monash University, Head of the Myeloma Research Group and Co-Director of the ACRF Blood Cancer Therapeutics Centre at the Australian Centre for Blood Diseases, Melbourne.

Associate Professor Eliza Hawkes

Lymphoma lead, Olivia Newton John Cancer Research Institute, Austin Health and Eastern Health, Melbourne.

Doctor Robin Gasiorowski

Consultant Haematologist, MQ Health & Concord Hospital and Senior Lecturer, Macquarie University & University of Sydney.

This webinars was created independently by the limbic. Thank you to Janssen-Cilag Pty Ltd for providing the non restrictive educational grant that made it possible.